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Abstract This research aims to determine the amount of radiation dose rate that can be accepted and the irradiation time 
that is required from Boron Neutron Capture Therapy (BNCT) cancer therapy to treat melanoma skin cancer. This research 
used the simulation program, MCNPX by defining the geometric dimensions of the tissue component, and describing the 
radiation source that were used. The outputs obtained from the MCNPX simulation were the neutron flux and the neutron 
scattering dose that came out from the collimator. The value of neutron flux was used to calculate the dose which comes 
from the interaction between the neutron and the material in the cancer tissue. Based on the results of the research, the 
dose rate to treat cancer tissue for boron is 10 μg/g of tumor, which translates to about 0.019241 Gy/second and  requires 
25.98 minutes of irradiation time, 15 μg/g of tumor translates to 0.021854 Gy/second and requires 2.,87 minutes, 20 μg/g 
of tumor translates to 0.022902 Gy/second and requires 21,83 minutes, 25 μg/g of tumor translates to 0.0271275 
Gy/second and requires 18.43 minutes, 30 μg/g of tumor translates to 0.0297658 Gy/second and requires 16.79 minutes, 
and 35 μg/g of tumor translates to 0.0343472 Gy/second and requires 14.55 minutes . The irradiation time needed for 
cancer tissue is shorter when boron concentration greater at the cancerous tissue. 
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INTRODUCTION 
Melanoma is a cancer that starts in a 
particular type of skin cell. To understand 
melanoma, it is beneficial to understand the 
normal structure and function of the skin. 
Melanoma is a cancer that begins in 
melanocytes. Other names for this cancer 
include malignant melanoma and cutaneous 
melanoma. Most melanoma cells still make 
melanin, so melanoma tumors are usually 
brown or black. But some melanomas do not 
make melanin and can appear pink, tan, or 
even white. [1] 
Current methods of cancer therapy 
include surgery or surgical methods, 
chemotherapy, and radiotherapy. Surgical 
methods involve the removal of cancerous tissue. 
Chemotherapy is a cancer therapy that uses drugs 
to kill cancer cells. Radiotherapy is a cancer 
therapy that uses particles or high-energy waves 
such as X-rays to kill cancer cells (American 
Cancer Society, 2015). This method utilizes 
ionization properties generated by sources in 
areas exposed to radiation exposure. The source 
of radiation can come from outside the body 
(external) or from within the body (internally) by 
an implant or embedded radioactive sources. 
Along with the development of technology, 
a safe radiotherapy method for cancer therapy, 
named Boron Neutron Capture Therapy (BNCT) 
is being developed. 
Boron Neutron Capture Therapy (BNCT) is 
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based on the ability of the non-radioactive 
isotope boron-10 to capture thermal neutrons. 
This nuclear reaction produces two high-LET 
particles (He-4 and Li-7) with a tissue range 
that is limited to the diameter of a single cell. 
This offers the possibility to target single 
tumor cells and to destroy them with high 
efficiency while sparing other healthy tissues 
containing less boron-10[2]. 
LITERATUR REVIEW 
Melanoma skin cancer is a type of skin 
cancer caused by the uncontrolled growth of 
melanocyte cells due to DNA damage. 
Melanoma is a rare type of skin cancer, but is 
more deadly than other types of skin cancer. 
That is because melanoma’s ability to 
metastasize to other organs is greater so that it 
causes the most deaths out of all skin cancer 
cases. Most melanomas will still produce 
melanin; therefore, melanoma skin cancer is 
usually brown or black. 
Melanoma can occur in all areas of the 
skin. In men it is usually found on the chest or 
back while in women it is usually found on the 
legs. However, melanomas can also be found 
on the face, neck, palms, soles of the feet, or 
under the nails. Melanoma is more common in 
people who have bright skin tones and are 
rarely found in dark-skinned people. Some of 
the following are the causes of a person being 
exposed to melanoma (American Cancer 
Society, 2016). 
BNCT combines the principles of 
chemotherapy and radiotherapy. The 
chemotherapy principle is due to the presence 
of boron-10, Sodium Boronocaptate (BSH) or 
Boronophenylalanine (BPA) compounds 
which are inserted into the patient's body first. 
The radiotherapy principle is included because 
the patient is later irradiated with a neutron 
source. Another advantage of BNCT is that the 
boron compound at a certain concentration is not 
toxic. The time interval between the 
administration of the boron compound and the 
neutron irradiation can be determined to optimize 
the ratio concentration of boron in the cancerous 
tissue and the boron in the healthy tissue. Only 
the tissue located around the cancerous tissue 
exposed to the effects of neutron irradiation and 
boron-10 need to be considered. Another reason 
for the selection of boron-10 is that it has a greater 
thermal neutron uptake than any other element in 
the body. 
Table 1. Comparison of Mid-Thermal Neutron Capture 
Views Multiple Elements (Soppera et al, 2012; Sauerwein, 
2012) 
Element Mass (%) Cross Section 
(barns) 
Hidrogen 10,5 32,945 
Oksigen  63,5 4,4814 
Nitrogen  2,5 13,481 
Karbon  22,6 5,576 
Kalsium 1,43 0,41 
Boron-10 - 3835 
In BNCT, there are three important factors 
that must be considered for cancer therapy with 
this method can be successful. These factors are 
the sources of neutrons used in irradiation, the 
boron compounds administered to the patient, and 
the resulting radiation dose. 
Table 2. Kriteria Sumber Neutron (IAEA, 2001; Fauziah, 
2013) 
Para 
meter 
Notation 
(satuan) 
IAEA 
Recommen
dation 
Collimator 
Output 
Epitherma
l neutron 
flux 
∅epi 
(𝑛 𝑐𝑚−2 𝑠−1) 
 
> 1,0 x 109 
 
1,65 x 109 
Rapid 
neutron 
dose 
rate/epithe
rmal 
neutron 
flux 
 
Dḟ /∅epi 
(𝐺𝑦 𝑐𝑚2 𝑛−1) 
 
< 2,0 x 10-13 
 
1,59 x 10-13 
Epidermal 
neutron 
gamma 
 
Dγ̇/∅epi 
(𝐺𝑦 𝑐𝑚2 𝑛−1) 
 
< 2,0 x 10-13 
 
1,16 x 10-13 
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Para 
meter 
Notation 
(satuan) 
IAEA 
Recommen
dation 
Collimator 
Output 
dose 
rat/flux 
density 
Epidermal 
neutron 
gamma 
dose 
rate/flux 
density 
 
∅th/∅epi 
 
< 0,05 
 
0,007 
The ratio 
between 
the 
neutron 
current 
and the 
neutron 
flux 
 
J/∅epi 
 
< 0,7 
 
0,72 
 
The Kartini Reactor is used as the neutron 
source in this study. Neutrons are passed 
through a conceptually designed collimator. A 
conceptual design of a collimator on the 
Kartini Reactor thermal column is made from 
several materials (Fauziah, 2013), as shown in 
Fig. 5 with the following sizes: 
1) Ni, with a thickness of 5 cm as a wall of the 
collimator, 
2) Al, with a thickness of 60 cm as a 
moderator, 
3) 60Ni, with a thickness of 15 cm as a filter 
4) Bi, with a thickness of 2 cm as a gamma ray 
shield  
5) 6Li2CO3-polietilen, with a thickness of 3 
cm as a neutron radiation barrier 
There two boron compounds used in 
BNCT, BSH (Sodium borocaptate, 
Na210B12H11SH) and BPA 
(Boronophenylalanine, C9H1210BNO4). 
Both compounds accumulate at different 
locations. BSH will accumulate on the cell 
membrane and BPA will accumulate on the 
cell nucleus.  
The boron compound that is already 
being used in clinical testing is BPA. 
Concentration of BPA in melanoma cancer cells 
have been observed to be about 1.6 times than in 
normal melanocyte cells. In addition, boron-10 
concentrations in cancer cells increased in the 
90th minute and were maximal at the 150 
minutes’ mark after injection into the body 
(Flores et al., 2012). 
In BNCT, there are four components of the 
dose that needs to be considered. 
1) Dose of Gamma (Dγ) 
The dose of gamma in the BNCT dose 
component comes from the reaction between 
hydrogen-1 in body tissues and thermal neutrons. 
The reaction produces gamma and hydrogen-2 
particles. The resulting hydrogen-2 is an excited 
atom, so it does not have a half-life. The resulting 
gamma particle has an energy of 2.33 MeV. The 
following is a reaction equation between 
hydrogen-1 and thermal neutrons (IAEA, 2001; 
Sauerwein, 2012). 
 H1
1 + n1
1  (0,025 eV) →  H1
2 +  γ (2,33 MeV) (2) 
2) Dose of Neutron Scattering (Dn) 
The neutrons produced by the reactor are not 
only thermal neutrons, but also fast neutrons. The 
interaction between neutrons and matter can 
produce recoil and photon radiation. The 
interaction that will occur is the neutron 
scattering reaction. It is characterized by the value 
of cross-sectional coefficient scattering on body 
tissues (IAEA, 2001; Sauerwein, 2012). 
3) Dose of Proton (DP)  
The dose of proton in the BNCT dose 
component is derived from the reaction between 
the thermal neutron and the nitrogen element in 
the body. The reaction will result in a carbon 
recoil and proton having an energy of 0.66 MeV 
(IAEA, 2001; Sauerwein, 2012). The following is 
the reaction equation between thermal neutrons 
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and nitrogen. 
N7
14 + n0
1 (0,025 MeV) →  C6
14 + p1
1  (0,66 𝑀𝑒𝑉) (3) 
4) Dose of Boron (DB) 
The boron dose is derived from the 
interaction between the thermal neutron and 
the boron compound injected into the 
cancerous tissue. The reactions between boron 
and thermal neutrons can be seen in equation 
1. The reaction between a thermal neutron and 
boron-10 in tissue have the highest probability 
of occurring because boron has a high thermal 
neutron catch crossover when compared to 
other elements, which is 3835 barn 
The Kartini Reactor (TRIGA MARK-II 
Reactor), located at the Center for Research on 
Pure and Instrumentation Materials (PPBMI) -
BATAN Yogyakarta, is one of three nuclear 
reactors in Indonesia. 
The Kartini reactor is a source of neutron 
radiation that is used for irradiation of 
melanoma on skin cancer patients. It produces 
not only thermal and epithermal neutrons but 
produces fast neutrons also. Regarding fast 
neutrons, there are other undesirable radiation 
beams due to its character, such as protons 
with high LET and free radicals (IAEA, 2001). 
This results in the need for a weight factor or 
radiation quality factor, so that the total dose 
received by organs is: 
𝐷𝑇 = 𝑤𝛾𝐷𝛾 + 𝑤𝑛𝐷𝑛 + 𝑤𝑝𝐷𝑝 + 𝑤𝐵𝐷𝐵 
Monte Carlo N-Particle (MCNP) is a 
particle transport analysis software and 
radiation transfer that uses a stochastic method 
called Monte Carlo. This software was 
developed by Los Alamos National 
Laboratory. MCNP software is continually 
being developed since its creation in 1940. The 
latest version is Monte Carlo N-Particle 
eXtended (MCNPX). This version is also 
continually being developed since its creation 
in 1994. MCNPX 2.6.0 is the last computer code 
released by the Radiation Safety Information 
Computational Center (RSICC). 
MCNPX uses continuous nuclear energy 
and nuclide data. The main sources of nuclear 
data are the evaluation data of the ENDF 
(Evaluated Nuclear Data File) system, the ACTI 
(Advanced Computational Technology 
Initiative), the EPDL (Evaluated Data Photon 
Library), the Livermore ACTL (The Activation 
Library), and the evaluation of Nuclear Physics ( 
T-16) Group 6, 7, 8 Los Alamos. MCNPX has 
capabilities that allow the user to specify the 
source conditions without having to make 
modifications to the whole code. MCNPX users 
can create input files for processing based on the 
desired calculations. This input file consists of 
geometry specification, material description, 
location of the neutron source, and the desired 
type of tally. Tally shows the information the user 
wants to collect. Tally MCNPX normalized per 
particle early, except in some special cases that 
have a critical source. The following is a tally 
provided by MCNPX (Booth, 2003; Muslih, 
2014). 
MATERIALS AND METHODS 
This research is a simulated study using 
MCNPX on melanoma skin cancer with a neutron 
source from a collimator design on the Kartini 
Reactor thermal column to find the dose value of 
BNCT and the time of irradiation necessary to kill 
the cancerous tissue. This research uses free 
variable in the form of boron concentration 
included in cancer tissue. 
This research was conducted in September 
2014 until December 2014 at the Accelerator and 
Materials Process Center of National Nuclear 
Energy Agency (PTAPB-BATAN) Yogyakarta. 
Research was conducted through the making of a 
source code for MCNPX which contains data of 
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geometric specification and material 
specifications of melanoma type cancer. 
This study uses a MCNPX-code with the 
Kartini Reactor as a neutron source which is 
accomplished by first collecting literature on 
skin cancer, especially skin cancer melanoma. 
In addition to collecting literature on 
melanoma skin cancer, literature on BNCT, 
Kartini Reactor, and MCNPX was also 
gathered. The next stage was to learn all the 
literature that had been collected and choose 
the type of skin cancer and its position. 
Followed by that, the volume of cancer 
cells and other tissues were counted. This is 
necessary because the tally used in this study 
requires volume input. After the organ 
geometry and collimator forms are completed, 
the next stage is to vary the boron in the atomic 
fraction part of the constituent material. We 
used 6 variations of boron, i.e. 10 μg/g cancer, 
15μg/g cancer, 20μg/g cancer, 25 μg/g cancer, 
30μg/g cancer, and 35μg/g of cancer. Once the 
specifications are ready, the MCNPX input 
code can be completed, therefore the next 
stage is running MCNPX with a command 
prompt application (cmd) to get thermal and 
epithermal neutron flux. The next step is to 
calculate the BNCT dose using Ms. 
Application Excel. Then analyze the data and 
graphs using the application origin 6.1 and 
draw conclusions from the research. 
The dose calculation for BNCT consists 
of four parts according to the neutron 
interaction that occurs. BNCT dose 
components include an alpha dose, a gamma 
dose from reactors and interaction with matter, 
a proton dose, and a neutron scattering dose. 
The results of the MCNPX code that can be 
used directly is the rate of gamma dose from 
the reactor and the dose of neutron scattering. 
The analysis is then continued by performing 
calculations using the Microsoft Excel 
application in accordance with the following 
steps: 
1. Calculation of the Number of Atoms in Tissue 
The number of atoms in a tissue indicates a 
possible reaction between neutrons and 
compounds during the irradiation process. The 
number of atoms in the network (Ni−tissue ) can be 
obtained by dividing the atomic number (Ni ) 
value of an element on a tissue with a mass of 
tissue (by kg unit) or can be written in the 
following equation (Berlianti, 2013): 
Ni−tissue =
Ni(atom)
mtissue(kg)
   (23) 
The value of the number of atoms can be 
obtained by multiplying the mole value of an 
element (ni) with the Avogadro number (NA =
6,023 x 1023 atom/mol), written in the following 
equation (Berlianti, 2013: 
Ni = niNA     (24) 
The mole value of an element is the result of 
the distribution of the mass of an element (mi)  
with the relative atomic mass (Ar) of that element, 
written in the following equation (Berlianti, 
2013): 
ni =  
mi (gram)
Ar(
gram
mol
)
     (25) 
2. Calculation of Dose Rate 
The rate of the components to be calculated 
manually has a difference in equation to that used. 
Calculations to be performed are: 
a. Gamma dose rate (thermal neutron reaction 
that results with hydrogen-1). 
The reaction between thermal neutrons and 
hydrogen-1 following equation 2, yields a 2.23 
MeV gamma particle. Calculation of the 
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deuterium formation rate is done because the 
rate of gamma formation in this reaction is 
equal to the rate of deuterium formation. The 
rate of gamma formation is calculated by the 
following equation (Berlianti, 2013; Irhas, 
2014): 
R⃛ =  ∅NH−tissueσH      (26) 
With   as the rate of formation of 
deuterium (hydrogen-2) or the rate of gamma 
particles being released, its units are 
photon/kg.s = Bq/kg; ∅ is a thermal neutron 
flux, which has a neutron.cm-2.s-1;   is the 
number of hydrogen atoms per kg of tissue, its 
units are/kg; And σ_H is the cross-sectional 
thermal neutron uptake of hydrogen, its units 
are cm2. 
The gamma-absorbing dose fraction is a 
coefficient that shows the dose the tissue 
receives from a given gamma radiation energy. 
Determination of the dose rate for gamma 
particles (Dγ) on the network is determined by 
the following equation (Berlianti, 2013; Irhas, 
2014): 
Dγ̇ = R⃛ ∆ φ   (27) 
(Dγ) is the rate of gamma dose, its units 
are Gy/s; Δ is the coefficient of absorptive dose 
rate/gamma specific activity from CGS to SI 
unit (1.6x10-13 x 2.33 MeV/ = 3.568 x10-13); 
And φ is a gamma-absorbing dose fraction 
(determined by looking at attachment 4). 
b. The rate of proton dose (thermal neutron 
reaction results with nitrogen-14) 
The proton dose rate comes from a thermal 
neutron catch reaction with nitrogen-14, which 
produces a carbon-14 and a 0.66 MeV energy 
proton. From that reaction, the proton dose rate 
is determined by the following equation 
(Berlianti, 2013; Irhas, 2014): 
?̇?𝑝𝑟𝑜𝑡𝑜𝑛 =  
∅ NN−jaringan σa,N Q 1,6x10
−13 J/MeV
1 
J/kg
Gy
    (28)  
Ḋproton is the rate of proton dose, its units 
are Gy/s; ∅ is a thermal neutron flux, which has a 
neutron.cm-2.s-1;  NN−tissue is the number of 
nitrogen atoms-14 per kg of tissue, its units are 
unit/kg of tissue; σa,N is a nitrogen-14 
microscopic latitude cross, its units are cm2; And 
Q is the energy of the particle, its units are MeV. 
c. Alpha dose rate (thermal neutron reaction 
result with boron-10) 
The alpha dose rate is obtained from the 
reaction between the thermal neutron and boron-
10, according to equation 1. The reaction yields 
an alpha particle with a mean energy of 2.33 
MeV. Calculation for the alpha dose rate uses the 
following equation (Berlianti, 2013; Irhas, 2014): 
?̇?𝑎𝑙𝑓𝑎 =
∅NB−tissue σa,B Q 1,6x10
−13 J/MeV
1
J/kg
Gy
   (29) 
Ḋalfa is the alpha dose rate,  its units are 
Gy/s; ∅ is a thermal neutron flux, which has a 
neutron.cm-2.s-1; NB−tissue Is the number of boron 
atoms-10 per kg of tissue, its units are/kg of 
tissue; σa,B is a microscopic cross-sectional 
absorption of boron-10 its units are cm 2; And Q 
is the energy of the particle, its units are MeV. 
d. Total dose rate 
The total dose rate analyzed in this study has 
the same principle as the equivalent dose in 
radiation protection. The equivalent dosage is a 
dose distribution especially used in radiation 
protection and states the extent of damage to 
tissues due to the absorption of some radiation 
energy by considering the factors that influence 
it. The equivalent dose is obtained by multiplying 
the absorbing dose by the radiation weight factor. 
Radiation weight factor is a coefficient that shows 
the destructive capability of radiation. 
Calculation of total dose rate is done using the 
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following equation (Berlianti, 2013; Irhas, 
2014): 
Ḋtotal =  walfaḊalfa + wprotonḊproton +
                  wneutronḊneutron + wγḊγ               (30) 
Ḋtotal is the total dose rate, its units are 
Gy/s; Walfa is the radiation weight factor of the 
alpha; Ḋalfa is the rate of alpha dosage, its units 
are Gy/s; wproton is the radiation weight factor 
of protons; Ḋproton is the proton dose rate, its 
units are Gy/s; wneutron is the radiation weight 
factor of neutrons; Ḋneutron is the dose rate of 
neutrons, its units are Gy/s; wγ  is the radiation 
weight factor of gamma; And Dγ is the rate of 
gamma dose, its units are Gy/s. 
Calculation of the total dose rate of each 
radiation has different contributions as 
described in Chapter 2 caused by RBE, CBE, 
and dose reduction factor factors. These 
differences are characterized by differences in 
radiation weight factor values. The radiation 
weight factor value is determined after 
considering factors affecting biological 
effects. The value is different depending on the 
type of radiation used. 
 
 
 
Table 3. Raw Factor Weight Ratio Value (Berlianti, 
2013; Irhas, 2014) 
Radiation Sources RBE Factor  
Alfa  3,8 (tumor) 
1,3 (soft tissue) 
Proton  2 
Neutron Scattering 3,2 
Gamma  1 
 
In the BNCT dose calculation, the 
absorption dose rate is multiplied by the 
radiation weight factor to obtain the dose of 
BNCT. This dose can be said as an isoeffective 
dose. An isoeffective dose is the dose unit used in 
clinical cases, which shows the relationship 
between absorbable doses induced by biological 
effects on the tissues. 
RESULTS AND ANALYSIS 
In this study, the neutron source used was the 
neutron source of the collimator output on the 
Kartini Reactor Thermal column, conceptually 
designed by Fauziah (2013). The collimator uses 
pure nickel with a thickness of 5 cm along the 
collimator wall, aluminum with a thickness of 60 
cm as a moderator, nickel-60 with a thickness of 
15 cm as a neutron filter, bismuth with a thickness 
of 2 cm as a gamma ray shield and 6Li2CO3-
polyethylene with a thickness of 3 cm as a neutron 
radiation barrier. The reason why this research 
uses this design is that its neutron output meets 
the IAEA recommendations. The drawing of the 
collimator design and its output can be seen in 
Figure 5 and Table 2 in the literature review 
section. The collimator design and the resulting 
neutron output are simulated using MCNP5. 
While in this study, the MCNPX was used, so 
researchers created a new collimator with the 
same design which yielded results similar to 
Fauziah collimator design (2013). 
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Figure 1. The design of the collimator along with the 
location of the irradiated organ is viewed from a side 
viewpoint. 
Figure 1 shows the collimator design used 
in this study along with the irradiated organs 
seen from the front viewpoint. The purple 
color shows the collimator wall, a 54 cm 
diameter cylinder and uses a pure nickel 
material of 5 cm thickness. The section in red 
shows the neutron moderator, a cylinder with 
a diameter of 44 cm and a thickness of 60 cm, 
and it uses aluminum material. The light blue 
color shows a neutron filter, a cylinder with a 
diameter of 44 cm and a thickness of 15 cm, 
and uses a nickel-60 material. The yellow 
color indicates the tip of the collimator and the 
irradiation site, which contains the air. Dark 
and green shades show a gamma ray shield and 
neutron radiation barrier. The pink section 
shows the upper arm that is affected by 
melanoma. The arm is in the form of a cylinder 
and has a diameter of 8.7 cm in which there is 
a bone with a diameter of 2.4 cm, muscle tissue 
and melanoma skin cancer tissue. 
 
Fig. 2 The Irradiation Organ Model 
 
Fig. 3 Skin Cancer Melanoma Model 
The input code of MCNPX used to find the 
value of the collimator output in this study uses a 
simulation to model the source of radiation 
(source definition or sdef). Sdef source modeling 
involves many variables that must be defined. 
These variables include the type of radiation 
beam, source form, energy and radiation direction 
along with its distribution. Each variable is 
represented by keywords written in the following 
format: 
sdef keyword1 keyword2  keyword3 ...keywordn  
The input codes for modeling the sources in 
this study are: 
sdef sur=2 ERG=0.1 AXS=1 0 0 par=n 
vec=1 0 0 dir=1. 
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The code shows that in the collimator 
there is a neutron at the point (0,0,0); 0.1 MeV 
energized; a neutron at the surface boundary 
(surface) 2; a neutron at the reference vector (1 
0 0). In addition, the authors also divide the 
neutron energies when out of the collimator 
into 3 energy categories; ≤ 5 × 10-7 MeV is a 
thermal neutron; ≤ 0.01 MeV is an epithermal 
neutron; and ≤ 20 MeV is a fast neutron. 
Table 4. Result of Fauziah collar eruption and Research 
Collimator 
Parameter Fauziah design 
collimator 
 
Research 
Collimator 
Thermal neutron 
flux 
 (n cm2 s-1) 
1.155 × 108 8.31952 × 
106 
Epitermal neutron 
flux 
 (n cm2 s-1) 
 
1.65 ×  109 
 
1.90346 ×  
109 
The ratio between 
thermal and 
epithermal flux 
neutrons 
 
0.007 
 
0.004 
Epidermal neutron 
gamma dose rate / 
flux density 
 (Gy cm2 n-1) 
 
1.16 ×  10-13 
 
2.515430 ×  
10-14 
 
 
In this study, the authors injected 6 
variations of boron concentration into cancer 
tissue, ie 10 μg/g of cancer; 15 μg/g of cancer; 
20 μg/g of cancer; 25 μg/g of cancer; 30 μg/g 
of cancer; And 35 μg/g of cancer. Each boron 
concentration is performed running MCNPX 
to obtain the neutron flux value in cancer and 
other tissues. 
Table 5. Neuton flux in every tissue with boron 
concentration 35 μg/g cancer. 
Tissue 
 
Cell 
number 
 
 
Depth 
(cm) 
 
Thermal 
neutron flux 
(n.cm-2.s-1) 
Epithermal 
neutron flux 
(n.cm-2.s-1) 
cancer 28 
0 
1,84335E+09 1,18980E+10 
ctv 
skin 29 
0,2 
8,20896E+09 2,05489E+11 
ptv 
skin 31 
0,2 
6,96633E+09 2,89141E+11 
ctv 
muscle 30 
0,6 
4,96145E+10 2,41593E+11 
Tissue 
 
Cell 
number 
 
 
Depth 
(cm) 
 
Thermal 
neutron flux 
(n.cm-2.s-1) 
Epithermal 
neutron flux 
(n.cm-2.s-1) 
ptv 
muscle 32 
0,9 
8,68118E+10 2,86912E+11 
otot 26 
1,2 
5,47110E+11 5,24331E+11 
bone 27 
3,25 
4,94017E+11 2,26496E+11 
slice 40 
4,45 
1,00961E+10 2,40921E+10 
 
The thermal and epithermal neutron flux 
values in the table have almost identical 
characteristics, i.e. the thermal and epithermal 
neutron flux values reach the highest point at a 
depth of 1.2 cm from the surface of the skin from 
the direction of the neutron radiation source, i.e., 
to the muscle tissue. This can be seen in Figure 2 
which shows the distribution of neutron flux at a 
certain depth in the arm organs for the 
concentration of boron 35 μg/g of cancer. 
 
Figure 2. Neutron Flux Distribution in Organs 
Figure 2 shows the change in the value of 
the neutron flux in the organs of the arm within a 
certain depth. The value of the thermal neutron 
flux increases at 0 cm and reaches the highest 
value at a depth of 1.2 cm and after a depth of 3.25 
cm, the value decreases significantly. Similarly, 
the flux value of epithermal neutrons has 
increased from a depth of 0 cm and reaches the 
highest value at a depth of 1.2 cm. However, at a 
depth of 4.45 cm the value is also still quite high. 
This suits the theory quite well. Because 
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according to the theory the value of thermal 
neutron flux reaches the highest peak at a 
depth of 0-2 cm and epithermal neutrons at a 
depth of 2 - 8 cm as shown in Figure 3 (IAEA, 
2001). 
 
Figure 3. The thermal and epithermal neutron flux 
distribution curves (IAEA, 2001) 
In BNCT dosimetry, there are four 
components of BNCT dose according to the 
interaction between neutrons with the body's 
tissue material. The dose component is the 
dose of neutron scattering, gamma dose, 
proton recoil dose and alpha dose. MCNPX 
output results that can be used directly i.e. 
thermal neutron flux and thermal neutron 
scattering dose in cancerous tissue. The value 
of the thermal neutron flux is used to find the 
gamma dose rate, proton dose rate and alpha 
dose rate. The gamma dose rate is derived from 
the results of the thermal neutron and 
hydrogen-1 reactions. The proton rate dose is 
derived from the thermal neutron catch 
reaction with nitrogen-14. While the alpha 
dose rate is derived from the reaction of 
thermal neutrons and boron-10. The dose rate 
is multiplied by the radiation weight factor to 
obtain the total dose rate. The radiation weight 
factor is the ratio of radiation that causes 
damage to tissues/organs. 
The dose rate for each component of BNCT 
dose has an increasing effect if boron 
concentration is increased. When calculating the 
dose rate, in addition to the thermal neutron flux, 
the value of the number of atoms is also used. The 
value of the number of atoms is influenced by the 
mass of the elements that interact with the thermal 
neutrons. The mass of the element boron-10 
changes according to its concentration variation 
as well as the constantly fixed mass of nitrogen 
and hydrogen affect this process. All calculations 
regarding the total dose rate are done manually by 
using the Microsoft Excel application. An 
example of calculating the total dose rate can be 
seen in Appendix 3. 
In BNCT, doses are used by a single 
fraction. A single fraction is a way of 
administering doses directly in one irradiation so 
it is worth noting the total dose received by 
healthy tissue. To determine whether the dose rate 
absorbed by body tissues is safe or not, a total 
absorption dose rate is used. The total absorption 
dosage is the result of multiplying the dose rate 
with irradiation time. The irradiation time is 
obtained from the minimal dosage of the cancer 
tissue damaged by the total dose rate (Berlianti, 
2013; Setiyadi, 2015). The minimum limit for 
killing melanoma skin cancer cells is 30-36 Gy 
(Anand, 2013). In this study, a dose of 30 Gy was 
used as a minimum dose to destroy cancer tissue. 
𝑡𝑖𝑚𝑒 𝑖𝑟𝑟𝑎𝑑𝑖𝑎𝑡𝑖𝑜𝑛 =  
30 (𝐺𝑦)
𝑡𝑜𝑡𝑎𝑙 𝑑𝑜𝑠𝑒 𝑟𝑎𝑡𝑒 (
𝐺𝑦
𝑑𝑒𝑡𝑖𝑘
)
            (31) 
Each variation of boron concentration for 
the total dose rate and irradiation time in this 
study can be seen in table 20. The amount of 
boron atom concentration required to kill cancer 
tissue is generally estimated at 109 atoms with a 
natural abundance of 19.9% per cell, which 
translates to about 35 μg/g cancer tissue. So in 
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this study the boron concentration used was 10 
μg-35 μg per gram of cancer tissue (Zhu et al. 
2010). 
Table 6. Dose Rate and Irradiation Time on Cancer 
Network 
Boron Concen 
tration 
(𝛍g/g cancer) 
Total Dose 
rate 
(Gy/s) 
Time 
Irradiation 
(s) 
Time 
Irradiation 
(min) 
10 0,019241 1559,176541 25,98628 
15 0,021854 1372,717077 22,87862 
20 0,022902 1309,929895 21,83216 
25 0,027128 1105,885096 18,43142 
30 0,029766 1007,866575 16,79778 
35 0,034347 873,4332847 14,55722 
 
From table 22, it can be seen the greater 
the value of boron concentration used, the 
greater the value of the total dose rate and the 
shorter the time required for irradiation. 
In order to obtain better results, the 
suggestions given for the next research are; 1) 
Making a human geometry intact, not just a 
piece of organs, 2) Further research should be 
done on the effect of doses on melanoma skin 
cancer using a collimator and the actual 
neutron source of the Kartini Reactor in order 
to obtain more accurate results, 3) Sampling of 
data should be more specific by taking data 
from the hospital for melanoma skin cancer 
patients. 
CONCLUSION 
1. The optimum boron concentration for 
treating skin cancer melanoma is 35 μg/g 
cancer which is achieved by considering 
the dose received by healthy tissue, ctv 
skin, skin ptv and cancer cells. 
2. The time taken to irradiate the melanoma 
skin cancer tissue is faster with the added 
concentration of boron used. The shortest 
time needed for the irradiation of 
melanoma skin cancer tissue is when a 
concentration of 35 μg/g of cancer is 
administered which has an irradiation time of 
14.55 minutes. 
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